Speakers

Ali Imran (MBBS, FRCP, FRCPC)

Ali Imran (MBBS, FRCP, FRCPC)

Division of Endocrinology, Dalhousie University, Halifax, Nova Scotia, Canada

Professor of Medicine

Arif Sheikh (MD)

Arif Sheikh (MD)

Diplomat American Board of Nuclear Medicine

MD, Diplomat American Board of Nuclear Medicine Diplomat American Board of Internal Medicine

Chief and Medical Director Theranostic Program Kettering Institute Ohio USA. 

More than 20 years’ experience of working in Nuclear Medicine in various renowned Nuclear Medicine and radiology departments in USA. He is member of various Nuclear Medicine and Radiology professional organizations. He is reviewer and editor of Nuclear Medicine related journals. He has Innumerable publications in reputed journals, book chapters, Tecdocs, guidelines etc.

Mohamed Haidar (MD)

Mohamed Haidar (MD)

Associate Professor in Clinical Diagnostic Radiology at the American University of Beirut

Dr Haidar Mohamad, President of the Arab Society of the Nuclear Medicine, is an Associate professor at the American University of Beirut and he is the director of Nuclear Medicine division and Cyclotron facility, as well as Director of the Nuclear Medicine Fellowship Program.

Apart from being an Associate professor in clinical diagnostic radiology at the American University of Beirut, he is currently a part-time professor in a number of well-known national universities.

Dr Haidar has delivered many talks and papers in national, regional and international meetings. He has received an award for his research work in 2009 at the Middle East Oncology Congress, (COMO VIII), Beirut, Lebanon and in 2018 at the Radiological society of North America (RSNA). Dr. Haidar is currently a member in different national and international scientific and medical societies.

SiJin Li (MD. Ph.D)

SiJin Li (MD. Ph.D)

President of Shanxi Medical University

President of Shanxi Medical University
Professor & Director of the Department of  Nuclear Medicine, the First Hospital of Shanxi Medical University.
Chairman of the Chinese Society of Nuclear Medicine

Main research interest is On Nuclear Cardiology and the representative papers have been published in JNM,  EJNMMI, JAHA, etc.

Hongcheng Shi

Hongcheng Shi

Vice President of Chinese Society of Nuclear Medicine.

Hongcheng Shi served as a director & professor in the department of nuclear medicine, Zhongshan Hospital, Fudan University. He is also served as a director in the institute of nuclear medicine, Fudan University and served as a vice director in the medical imaging institute in Shanghai. He is a vice President of Chinese Society of Nuclear Medicine. 
Dr. Shi is good at hybrid imaging diagnostic work, such as SPECT/CT and PET/CT. As an editor in chief, he published 3 books in Chinese, including "Nuclear Cardiology", "Procedure guideline and clinical application of hybrid SPECT/diagnostic CT" and "PET/CT clinical Evidence-based practice and procedure guidance". As the first author or corresponding author, he has published more than 200 papers in peer-reviewed journals.
Dr.Shi got ACNM Honorary Fellow in 2017, and SNMMI Presidential Distinguished Service Award in 2020. He also got many awards in China, such as “Top 10 Best Doctors in Shanghai”, and so on.
Dr. Shi is the first user of the total body PET/CT in the world. His team have examined more than 7,000 patients in his department in the past and accumulated a lot of experience in using total body PET/CT. His team have published many manuscripts in JNM, EJNM and AJR to introduce the clinical application of total body PET in different fields. 

Sharjeel Usmani (KBNM, FEBNM, CBNC, MS, Dip stat)

Sharjeel Usmani (KBNM, FEBNM, CBNC, MS, Dip stat)

Specialist Nuclear Medicine at Kuwait Cancer Control Center Teaching staff at Kuwait Institute of Medical Specialization

Awards/Achievements:
Outstanding Doctor Award in KCCC for year of 2016
Most hardworking house officer: 2002 - Dept. of Medicine, Civil
Hospital Karachi, Pakistan
Special interest:
a) 18F- NaF Bone Imaging and SPECT-CT hybrid imaging
b) 68 Ga-PSMA Imaging in Prostate Cancer
c) 177Lu PSMA-617 therapy in hormone-refractory prostate cancers
d) 177Lu-DOTATATE Peptide receptor radionuclide therapy
e) Positron Emission Mammography

Research Interest
My main research interest is in bone imaging with 18F-NaF PET/CT which is commonly used
in imaging patients with cancer, however my additional interest is to build clinical value of 18FNaF
PET/CT in non-oncological indications and special patient populations. I also derive
considerable pleasure from research and using my statistical skills able to organize and publish
more than 90 original articles and 98 abstracts. I have keen interest in breast imaging and
published 11 original articles in this meadow.
Clinical Interest
Attracted to physiological and molecular imaging but my current post in Nuclear Medicine and
particularly hybrid imaging has particularly stimulated my interest in infection, hypoxia,
receptors and peptide imaging and therapy. I am also very interested in implementing prostatespecific
membrane antigen (PSMA) theranostic agents 177Lu-PSMA-617 and 225Ac-PSMA-
617 radionuclide alpha therapy in treatment of hormone-refractory metastatic prostate cancers.
Other clinical interest is to utilize positron emission mammography (PEM) in response
evaluation of neoadjuvant chemotherapy in locally advanced breast cancer.

Xiaoli Zhang

Xiaoli Zhang

Director and Professor in Department of Nuclear Medicine, Beijing Anzhen hospital, Capital Medical University

Xiaoli Zhang served as a director and professor in Department of Nuclear Medicine, Beijing Anzhen hospital, Capital Medical University. She is a standing committee member, Chair of International Liaison Committee member, Chinese Society of Nuclear Medicine. 
Dr. Zhang worked in Nuclear Cardiology for 30 years. She mainly focused on viability assessment, myocardial flow reserve, LV remodeling, prognostic value in patients with aneurysm, and ischemia cardiopathy by gated perfusion and gated 18F-FDG PET studies. She is the first doctor who performed viability assessment by 18F-FDG PET made in China. She also performed dynamic multi-target molecular imaging (ammonia/FDG/FDPA) in different kind of animal models at different stages in AMI, hibernation, IRI and aneurysm model, and to evaluate the effects of metformin and remote ischemic preconditioning in IRI, and to elucidate the mechanism of IR, hibernation, and so on.   
Zhang got twice Young Investigator Award by SNMMI (2004, 2007). And her team got YIA in 2020 by SNMMI. She also got many awards in China. She has published more than 140 manuscripts in peer-reviewed journals and more than 50 abstracts in SNMMI and ENM meeting, and 5 abstracts were selected by Nuclear Cardiology highlights section.

Yansong Lin

Yansong Lin

Professor of nuclear medicine in the department of nuclear medicine, Peking Union Medical College (PUMC) Hospital

Yansong Lin, a professor of nuclear medicine in the department of nuclear medicine, Peking Union Medical College (PUMC) Hospital, Chinese Academy of Medical Sciences & PUMC, is also director of the Experts Committee on Nuclear Medicine, Chinese Society of Clinical Oncology (CSCO). 
Dr. Lin is an expert in nuclear medical diagnosis, treatment, and patient-management for differentiated thyroid cancer (DTC). During recent 10 years, she has published 9 handbooks, guidelines and consensuses in Chinese as an editor-in-chief, (including "Handbooks of thyroid cancer ", " Guidelines for diagnosis and treatment of persistent / recurrent and metastatic thyroid cancer", and " Expert consensus on 131I pre-treatment evaluation after surgery for differentiated thyroid cancer "), and more than 100 papers as the first author or corresponding author.
Apart from academic achievements, Dr. Lin is also admired and respected by patients and fellows. She was awarded as the 2019 respectable doctors in China, and got the Third prize of Chinese medical science and Technology Award for 3 times, etc.
Furthermore, Dr. Lin has made great contributions in clinical trials, thereby benefiting Chinese patients with alternative treatment strategies. She has conducted more than 10 international and domestic clinical trials as PIs, involved Sorafenib, Donafenib, Apatini and other anti-tumor drugs, expected to slow down the progression of disease and improve the overall survival rate of patients in advanced stage of thyroid cancer. Meanwhile, she is concentrated on exploring the relation between serum markers, genetic molecular typing and DTC as well as establishing a more rational evaluation system. Relevant results were published on Thyroid, JNM, CNM, EJNMMI etc.
 

Geoff Currie

Geoff Currie

Professor in Nuclear Medicine at Charles Sturt University in Australia

Prof Geoff Currie is Professor in Nuclear Medicine at Charles Sturt University in Australia and Professor in Radiology at Baylor College of Medicine in the USA. He has more than 170 peer reviewed journal articles, 5 book chapters, 1 book and over 160 conference presentations. Prof Currie has a significant footprint in artificial intelligence in nuclear medicine through journal publication, invited conference and webinar presentations, teaching and research

Muhammad Umar Khan (MBBS, FCPS)

Muhammad Umar Khan (MBBS, FCPS)

Consultant in Nuclear Medicine and PET/CT imaging at the Department of Medical Imaging, Al-Jahra Hospital, Ministry of Health, Kuwait

Dr. Muhammad Umar Khan is a Consultant in Nuclear Medicine and PET/CT imaging at the Department
of Medical Imaging, Al-Jahra Hospital, Ministry of Health, Kuwait. Dr. Khan trained in PET/CT & PET/MR
Imaging at the Clinical PET Center St. Thomas’ Hospital, Institute of Nuclear Medicine UCLH, and the
Hammersmith Hospital, Imperial Healthcare, NHS, London UK. He is a recipient of the EANM Marie Curie
training grant for PET/CT training as well as the UICC ICRETT fellowship. Dr. Khan is a Union of
International Cancer Control (UICC) Fellow and did his Radio-immunotherapy fellowship at the Royal
Free Hospital, UK. He has also received the ARCCNM and INCTR awards for his research papers. He is the
Site Co-coordinator/Training Supervisor for the Kuwaiti Board Nuclear Medicine residency training
program. His areas of interest are molecular imaging in nuclear oncology and hybrid imaging (PET/CT &
PET/MR). Dr. Khan has contributed various publications and book chapters in peer reviewed indexed
journals.

Fahim Ul Hassan (MBBS.MRCP.MSc.FRCP)

Fahim Ul Hassan (MBBS.MRCP.MSc.FRCP)

Consultant Nuclear Medicine Physician at Guy’s and St Thomas NHS Trus

Fahim Ul Hassan is a consultant Nuclear Medicine Physician at Guy’s and St Thomas NHS Trust. After completing MRCP and some years of training in General Medicine and Pulmonology, joined Guy’s and St Thomas as a nuclear medicine specialist trainee in 2008. He has been in his current role since February 2013. His specialist interests include radionuclide therapies and hybrid imaging. He is a key member of thyroid cancer MDM, which is one of the largest in United Kingdom. He is the principle site investigator of IoN trial . He is actively involved in teaching and examining undergraduate as well as teaching and supervising MSc nuclear medicine students in King’s College London

Zaheer Chiragh

Zaheer Chiragh

Consultant Nuclear Medicine Physician at the Gurayat General Hospital-KSA

Dr. Zaheer Chiragh is a Consultant Nuclear Medicine Physician at the Gurayat General Hospital-KSA. He did his MS in Nuclear Medicine from Pakistan Institute of Engineering and Applied Sciences (PIEAS ) in 2007. He joined Bahawalpur Institute of Nuclear Medicine & Oncology (BINO) and worked there for 5 years. He did his Fellowship in Nuclear Medicine PET-CT imaging from Nuclear Medicine & PET Imaging department of Singapore General Hospital. He served as head of nuclear medicine department in Social Security Hospital Lahore. Dr Zaheer did Fellowship European Board of Nuclear Medicine certification in 2013. He joined Ministry of Health KSA in 2014 and has established Nuclear Medicine Department and currently serving as consultant and head of Nuclear Medicine there. Dr Zaheer has various research projects and publications to his credit. His research interests are radioimmunotherapy, theranostics and healthcare quality management

Humayun Bashir

Humayun Bashir

Consultant & Head of Nuclear Medicine Departments, Shaukat Khanum Memorial Trust Hospitals, Pakistan

Consultant & Head of Nuclear Medicine Departments, Shaukat Khanum Memorial Trust Hospitals, Pakistan

Nuclear Medicine Physician with over 20 years of experience in the specialty acquired in Pakistan, United Kingdom and Saudi Arabia.

Special interest in hybrid scintigraphy and Theranostics.

Thirty five indexed publications with 195 citations.

·       Fellow of the College of Physicians and Surgeons Pakistan (Pk)

·       Fellow of the Royal of College Physicians of Edinburgh(UK)

·       Fellow of the Royal of College Physicians London (UK)

·       Fellow of the European Board of Nuclear Medicine(EU)

·       Diplomate of the Certification Board of Nuclear Cardiology:2006-16 (USA)

·       Henri Becquerel Fellowship in Pediatric Nuclear Medicine (UK)

·      Member Board of Directors of the Asia Oceanic Federation of Nuclear Medicine and Biology (AOFNMB)

·        Past president of the Pakistan Society of Nuclear Medicine (2015-17)

·       Chair of the 1st Sino-Pak Nuclear Medicine Symposium (2017)

Shazia Fatima (MBBS, MS, FCPS, PGD)

Shazia Fatima (MBBS, MS, FCPS, PGD)

Head Department of Nuclear Medicine & Pathology Atomic Energy Cancer Hospital -NORI (AECH-NORI)

Job Title: Head Department of Nuclear Medicine & Pathology Atomic Energy Cancer
Hospital -NORI (AECH-NORI)
Medical doctor with post graduate degree in Nuclear Medicine and biomedical ethics.
President Pakistan Society of Nuclear Medicine. Have worked in Pakistan Atomic Energy
Cancer Hospital NORI for last 22 years. Currently heading department of Nuclear
Medicine and Pathology.
President Pakistan Society of Nuclear Medicine – first elected female president of this
professional society
Awards/Achievements:
o Member governing body of WARMTH (World Association of
Radiophrmaceuticals and therapy) . First and only elected member of this world
level organization.
o Selected as an expert in the field of Nuclear Medicine by International atomic
energy agency (IAEA) expert mission to various developing countries. Only femal
from Pakistan to represent our country at an expert level
o Member in various international committees for international project
formulation.
o Received various awards for paper and poster presentation in local and
international conferences,
o Multiple national and international research projects
o Principal Investigator of following international projects;
o IAEA project on spinal infection imaging
o Country coordinator of QUANAM  and QUADRIL audits  of IAEA

o Principal investigator in international multi-institutional epidemiological
study “WP3:EUTyhroid- Dried Blood Sample Thyroglobulin ( DBS-Tg) in
euthyroid pregnant women”

o Represented Pakistan at various international forums, conferences, meetings
and symposiums.
o Member Editorial Board World Journal of Nuclear Medicine and managing editor
Pakistan Journal of Nuclear Medicine
o Extensive teaching and training experience in Nuclear Medicine post graduate
training of doctors and technologists
o Excellent interpersonal, Communication and Conflict Resolving Skills

Abdelhamid H. Elgazzar

Abdelhamid H. Elgazzar

Professor and chairman of the Nuclear Medicine Department at Kuwait University.

• Graduated from the School of Medicine of the University of Cairo, Egypt.
• Received his training in Clinical and Anatomic Pathology at the University Of Kansas School Of Medicine and his Nuclear Medicine training from the University Of Cincinnati School Of Medicine, Cincinnati, Ohio, USA.
• Is board certified by the American Board of Anatomical and Clinical Pathology as well as by the American Board of Nuclear Medicine.
• Is a fellow of the College of American Pathologists
• Worked as a faculty staff at the University of Cincinnati School of Medicine, the Mount Sinai School of Medicine, New York and as a chief of Nuclear Medicine at Tufts-new England medical center, Boston
• Is currently a professor and chairman of the Nuclear Medicine Department at Kuwait University.
• Has received 14 awards from several international professional organizations.
• Is a member of the editorial boards of several medical journals
• Has authored and co-authored over 150 peer-reviewed scientific articles and has authored and edited 10 textbooks and six book chapters 
• Has served as a reviewer of the Journal of Nuclear Medicine, and several other medical journals

Durr-e-Sabih

Durr-e-Sabih

Chair of the Asian Nuclear Medicine Board and on the executive committees of the ARCCNM and AOFNMB

Dr. Durr-e-Sabih retired as Director Multan Institute of Nuclear Medicine and Radiotherapy in 2017.  He has been an IAEA expert and one of the documents (Nuclear Medicine Resource Manual) he co-authored has been published recently by the IAEA human health campus.

He was the founding editor of the Pakistan Journal of Nuclear Medicine and the first elected President of the Pakistan Society of Nuclear Medicine.

He is presently chair of the Asian Nuclear Medicine Board and on the executive committees of the ARCCNM and AOFNMB.

He has a patent for a device to help with chorionic villous sampling and has authored or co-authored over 70 peer reviewed articles and editorials and over 10 books.

Jean Luc Urbain

Jean Luc Urbain

Presidency of the World Federation of Nuclear Medicine and Biology.

A native of Belgium, Dr. Urbain earned his Medical Degree at the University of Louvain, Belgium, and then pursued residency training in Internal Medicine and Nuclear Medicine at the University Hospital of the University of Louvain in Brussels, Belgium. He subsequently obtained a Ph.D. in Genetics and Molecular Biology at Temple University in Philadelphia. Professor of Imaging, Medicine and Biology for more than two decades, Urbain has held leadership and executive positions in Medical Imaging and Medicine in Belgium at the University of Leuven, in Canada at the University of Western Ontario and in the US at Temple University, Fox Chase Cancer Center, The Cleveland Clinic, the VA Administration and now Wake Forest University/Baptist Medical Center. During his career he had the opportunity and privilege to visit hospitals and medical centers and give lecture on all continents.
Urbain has extensive experience and expertise in committees and boards leadership, in the management of integrated health care systems and patient advocacy groups and at regional, national and international levels of government. He has also served as consultant and advisor for Pharmaceutical, Radiopharmaceutical and Medical Systems companies. He worked closely with
national and international medical associations and government health authorities to mitigate the major health and medical isotopes crises of 2007-2008, analyzed and helped establish medical resources needs, benchmarks and allocation for key medical service areas.
Urbain was appointed as Secretary of the Belgian Society of Nuclear Medicine in the early 90s’, President of the Canadian Association of Nuclear Medicine (CANM 2006-2011) and President of the Easter Great Lakes Chapter of the SNMMI (2010-2012). On January 1st, 2021 Dr. Urbain started to assume the Presidency of the World Federation of Nuclear Medicine and Biology.
His current interests are in Precision Medicine and Theranostics, Graduate and Postgraduate Physicians Education, Patients’ Education and Advocacy.

M. Khalid Nawaz

M. Khalid Nawaz

Consultant Nuclear Medicine at PKLI & RC since 2017

  • Graduate from King Edward Medical College, Lahore – 1973
  • Got Training in Nuclear Medicine at St. Bartholomew’s Hospital London, U.K from 1979 – 1981.
  • Consultant Nuclear Medicine in Kuwait from 1983 – 2000.
  • Consultant Nuclear Medicine in SKMCH & RC from 2000 – 2017.
  • Consultant Nuclear Medicine at PKLI & RC since 2017.
  • Ex-Elected General Secretary & President of PSNM
  • More than 130 Papers and Publications

2021 © All rights reserved - Crafted with by Discover Digitals